Filter
961
Text search:
European
Medicines
Agency
Featured
Recommendations
100
New Publications
212
Language
Document type
No document type
424
Studies & Reports
226
Guidelines
154
Manuals
56
Strategic & Response Plan
43
Fact sheets
29
Situation Updates
15
Training Material
9
Resource Platforms
3
Brochures
1
Online Courses
1
Countries / Regions
Western and Central Europe
60
Global
46
Ukraine
38
Eastern Europe
25
Africa
22
Sierra Leone
20
Nigeria
18
Liberia
16
Ghana
16
Kenya
16
Nepal
14
Ethiopia
12
Myanmar / Burma
12
Zambia
11
Syria
10
Latin America and the Carribbean
10
India
9
Germany
9
Eastern Europe and Central Asia
9
Guinea
8
Uganda
8
Philippines
8
Rwanda
8
South Africa
8
Bangladesh
8
Moldova
8
Congo, Democratic Republic of
7
West and Central Africa
7
Zimbabwe
6
Thailand
6
Indonesia
6
Burkina Faso
5
South Sudan
5
Tanzania
5
Malawi
5
East and Southern Africa
5
South–East Asia Region
5
Russia
5
Senegal
4
Jordan
4
Namibia
4
Brazil
4
Hungary
4
Botswana
4
Middle East and North Africa
4
Asia
4
Venezuela
4
Poland
4
Georgia
4
Pakistan
3
Cambodia
3
North Macedonia
3
Yemen
3
Albania
3
Romania
3
Jamaica
3
Morocco
2
Afghanistan
2
Lebanon
2
Mozambique
2
Sudan
2
Argentina
2
Eswatini/ Swaziland
2
Serbia
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Bulgaria
2
Iran
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Turkey
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Colombia
1
Ecuador
1
Bolivia
1
Greece
1
Lesotho
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Mongolia
1
Slovakia
1
Kyrgyzstan
1
Australia
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
259
Clinical Guidelines
111
Public Health
57
Women & Child Health
41
Key Resources
28
Pharmacy & Technologies
23
Capacity Building
9
Toolboxes
AMR
90
COVID-19
89
TB
84
HIV
79
Mental Health
66
Pharmacy
53
Conflict
45
Rapid Response
32
Planetary Health
31
Ebola
27
Global Health Education
26
Refugee
23
Disability
18
NCDs
18
Health Financing Toolbox
15
Caregiver
14
NTDs
13
Natural Hazards
9
Zika
7
Specific Hazards
5
Polio
4
Cholera
2
July 2019
Policy brief
HIV Treatment
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
HIV i-Base
July 2018
Technical Update
HIV Treatment
July 2017
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr
...
Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended
To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo
...
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ
...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta
...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta
...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta
...
16.7.2021
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
